Can you sue vaccine manufacturers for injuries? A primary source guide to the legal protections shielding vaccine makers from liability — from the 1986 Act to Bruesewitz v. Wyeth.
Vaccine manufacturers are the only consumer product companies that can harm or kill customers with near-complete legal impunity — a status created by the 1986 Act (National Childhood Vaccine Injury Act) and upheld by the United States Supreme Court.
Explanation
The 1986 Act explicitly bars civil actions for damages against vaccine manufacturers for vaccine-related injuries and deaths. As the law states: "No person may bring a civil action for damages in an amount greater than $1,000 … against a vaccine administrator or manufacturer … for damages arising from a vaccine-related injury or death."
Injured individuals must instead bring claims against the Secretary of HHS through the VICP (Vaccine Injury Compensation Program) — suing the federal government, not the company that profited from the vaccine.
The Design Defect Barrier
After exhausting the VICP, an injured person may technically bring a claim in court against the manufacturer, but only if they can prove fraud. The U.S. Supreme Court eliminated all "design defect" claims against vaccine manufacturers, ruling: "we hold that the National Childhood Vaccine Injury Act preempts all design-defect claims against vaccine manufacturers brought by plaintiffs who seek compensation for injury or death caused by vaccine side effects."
The dissent by Justices Sonia Sotomayor and Ruth Bader Ginsburg argued: "The majority's decision leaves a regulatory vacuum in which no one—neither the FDA nor any other federal agency, nor state and federal juries—ensures that vaccine manufacturers adequately take account of scientific and technological advancements."
Evidence and Examples
Critics argue the immunity is structurally irrational because:
Drugs with serious known risks and small markets remain profitable without immunity, because companies can limit liability by making drugs as safe as technologically feasible and disclosing risks
The same two adjustments — safer design and full disclosure — would theoretically protect vaccine makers from most liability without needing blanket immunity
In 2019, Pfizer generated $5.95 billion from a single childhood vaccine (Prevnar-13 alone)
The global vaccine market is projected to exceed $153 billion by 2028
All 50 states mandate vaccines for school enrollment; the federal government purchases billions in vaccines annually and markets them using taxpayer dollars — giving manufacturers a guaranteed, captive market with free marketing
Under the current framework, vaccine manufacturers benefit from a uniquely favorable arrangement: government-funded development, taxpayer-financed marketing and purchasing, state-level mandates that guarantee a captive market, and statutory immunity from liability for injuries — a combination of protections available to no other consumer product category.
The Perverse Incentive
Typically, a company's liability drives them to test safety rigorously and monitor products after release. Removing that liability inverts the incentive: vaccine makers have a financial disincentive to find or disclose safety problems, since immunity means safety failures don't cost them anything.
Because vaccines carry no tort liability, products that would face market withdrawal under normal pharmaceutical liability standards face no equivalent pressure — the economic feedback loop that removes dangerous drugs from shelves does not apply.
Significance
Critics argue this is the foundational structural problem underlying all vaccine safety issues: without liability, neither pre-licensure testing depth nor post-licensure monitoring has economic pressure behind it. Combined with Regulatory Capture by HHS, this creates a system with no effective safety enforcement mechanism.
Why can't you sue a vaccine manufacturer if your child is injured?
The 1986 National Childhood Vaccine Injury Act bars civil actions for damages against vaccine manufacturers for vaccine-related injuries and deaths. Injured individuals must instead file claims against the Secretary of HHS through the Vaccine Injury Compensation Program (VICP). The U.S. Supreme Court further eliminated all "design defect" claims in Bruesewitz v. Wyeth, ruling that the 1986 Act preempts such claims entirely.
What did the Supreme Court rule in Bruesewitz v. Wyeth about vaccine liability?
The Supreme Court held that the 1986 Act preempts all design-defect claims against vaccine manufacturers brought by plaintiffs seeking compensation for injury or death caused by vaccine side effects. Justices Sotomayor and Ginsburg dissented, warning the ruling "leaves a regulatory vacuum in which no one ensures that vaccine manufacturers adequately take account of scientific and technological advancements."
How much money do vaccine manufacturers make despite having no liability?
In 2019, Pfizer generated $5.95 billion from a single childhood vaccine (Prevnar-13 alone). The global vaccine market is projected to exceed $153 billion by 2028. Manufacturers benefit from government-funded development, taxpayer-financed marketing and purchasing, state-level mandates guaranteeing a captive market, and statutory immunity from liability — a combination of protections available to no other consumer product category.
Does removing liability actually affect vaccine safety?
Liability normally drives companies to test safety rigorously and monitor products after release. Removing it inverts the incentive — vaccine makers have a financial disincentive to find or disclose safety problems since immunity means safety failures cost them nothing. Products that would face market withdrawal under normal pharmaceutical liability standards face no equivalent pressure because the economic feedback loop that removes dangerous drugs from shelves does not apply to vaccines.
Can you sue a vaccine maker for anything after going through vaccine court?
After exhausting the VICP, an injured person may technically bring a claim in court against the manufacturer, but only if they can prove fraud. The Supreme Court's Bruesewitz v. Wyeth decision eliminated all design defect claims, making successful post-VICP suits extremely rare. The only remaining avenue is proving the manufacturer engaged in outright fraud — an exceptionally high legal bar.
This is the plain-HTML rendering of concepts/Financial Immunity for Vaccine Makers.md, served for search
engines, AI crawlers, and accessibility tools. The interactive 3D version
of this wiki lives at vaccine-safety.org.